Sign Out
Atrophic gastritis has been reported in long-term treatment with Omeprazole.
The dose should be adjusted and monitored in hepatic impairment patients.
Gastric malignancy: administration of Omeprazole can suppress the symptoms and diagnosis of malignancy.
The bioavailability of the drug may be increased in elderly, different race and hepatic impairment patients.
